510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K851639Substantially Equivalent

Anti-Leu-12 B Cell Reagent

BD Becton Dickinson Vacutainer Systems Preanalytic, Washington DC / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K851639 is the FDA 510(k) clearance record for ANTI-LEU-12 B CELL REAGENT, a class II device, cleared for Bd Becton Dickinson Vacutainer Systems Preanalytic on under FDA product code LJD (Assay, B Lymphocyte Marker). FDA records list 632 510(k) clearances for Bd Becton Dickinson Vacutainer Systems Preanalytic, from to . As of , FDA records show no recalls naming K851639.

Clearance record

Decision date
Received
(439 days to decision)
Product code
LJD Assay, B Lymphocyte Marker
Regulation
21 CFR 864.5220
Device class
Class II
Review panel
Hematology
Applicant
Bd Becton Dickinson Vacutainer Systems Preanalytic 1875 Eye St. NW Suite 625, Washington DC
Third party review
No

Clearances, product code LJD

Trailing 12 months

FDA records hold no clearances under product code LJD in the trailing twelve months.

FDA records show no clearances under product code LJD in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LJD, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260